In this study, we examined whether IL-17A/IL-17RA promotes pancreatic ductal adenocarcinoma (PDAC) aggressiveness in terms of survival and cancer stem cell modulation. This evidence concerns the gene IL17A and pancreatic ductal adenocarcinoma.